Vascular dysfunction is implicated in the pathogenesis of osteoarthritis (OA). Herein, we utilized smooth muscle specific human Sirt1 transgenic (smSirt1-Tg) mice characterized by vascular homeostasis to prepare an OA model to validate vasculature-derived articular cartilage protective factors. The OA of smSirt1-Tg mice exhibited significantly reduced cartilage destruction and pain sensitivity, accompanied by increased proteoglycans content and collagen type II (Col2É) expression and decreased matrix metallopeptidase 13 (MMP13) and p53 expression. Vascular smooth muscle cell-derived cZFP609 was highly enriched in the articular cartilage and plasma of smSirt1-Tg mice. Overexpression of cZFP609 abrogated TNFα-induced endoplasmic reticulum (ER) stress and fine-tuned the mitochondrial homeostasis in chondrocytes. Mechanistically, cZFP609, located in the cytoplasm, interacted with binding immunoglobulin protein (BiP) to stabilize the BiP oligomeric form. This interaction reduced the level of active BiP monomer that induced not only ER stress via activating IRE1α (inositol-requiring enzyme 1α) signaling but also mediated the formation of ER-mitochondria contacts (ERMCs). Increased oligomeric BiP by overexpression of cZFP609 suppressed ERMC-driven aberrant ER-mitochondria communication and diminished lipid peroxidation and ferroptosis, which contributed to maintaining mitochondrial homeostasis and alleviating cartilage degeneration in OA. Taken together, these results elucidate a beneficial cZFP609-driven feed-forward circuit that can be effectively targeted to stem the progression of OA.
cZFP609 Tethering BiP Alleviates Cartilage Degradation in Osteoarthritis via Remedying Aberrant ER-Mitochondrial Contacts.
cZFP609 锚定 BiP 通过修复异常的内质网-线粒体接触来缓解骨关节炎中的软骨退化。
阅读:4
作者:
| 期刊: | MedComm | 影响因子: | 10.700 |
| 时间: | 2025 | 起止号: | 2025 Oct 13; 6(10):e70405 |
| doi: | 10.1002/mco2.70405 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
